Initiative will deploy predictive big data analytics to analyze patient data from landmark CoMMpass Studya to speed drug discovery and development for patients with multiple myeloma CAMBRIDGE, Mass. & NORWALK, Conn.-- -- GNS Healthcare , a leading provider of analytics solutions for driving personalized interventions that improve population health, and the Multiple Myeloma Research Foundation , a leader in accelerating the development of breakthrough multiple myeloma therapies, today announced a collaboration to speed the discovery of innovative treatments for patients with multiple myeloma.
via Norwalk Newswire http://www.biospace.com/news_story.aspx?StoryID=360201&full=1
via Norwalk Newswire http://www.biospace.com/news_story.aspx?StoryID=360201&full=1
No comments:
Post a Comment